Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.
 Your new post is loading...
Your new post is loading...
Scoop.it!
I am tremendously excited by the potential synergies between digital health and medical product development; capturing this value, however, will require a sophisticated understanding -- not only of the technologies, but also of the specific... Via Gilles Jourquin 
No comment yet.
Sign up to comment
Scoop.it!
David Shaywitz writes:
As pharma companies confront the digital health wave and contemplate their digital health strategy, I see four high-level options:
1. Opportunistic adjacency: Leverage healthcare knowledge and regulatory expertise to develop technology in a related but distinct area, ultimately anticipating it evolves into a discrete business unit, analogous to animal health (e.g. Lilly’s Elanco), generics (Novartis subsidiary Sandoz), nutrition, and consumer health.
2. Follow with interest: Determine that digital health, while promising, is still in its earliest days. Just as some pharmas may be relieved they resisted investing in the first round of stem cell technologies, for instance, they might be similarly inclined to adopt a watchful waiting posture, and give the field some time to settle out. Functional areas could utilize specific digital health solutions when they evolve to the point they are available from vendors, similar to the way other solutions are utilized by the industry. 3. Elevate: Set up a dedicated “digital health” division envisioned not as a standalone business unit, but tightly integrated and explicitly intended to support the main pharma business, similar to the way many companies have dedicated “biomarker” divisions, for example. This group could be responsible for monitoring external developments and internalizing and operationalizing the most promising technologies. 4. Planned obsolescence: My personal choice, this approach would set up a dedicated “digital health” group, as in 3, but with the stated mission of catalyzing technology adoption, and with the explicit expectation that it would wind down within a set time (say five years). If successful, awareness of the relevant digital health opportunities and expertise in their appropriate utilization would by that point be located in the individual functional areas.
Via Chatu Jayadewa
Scoop.it!
Ever Increasingly, Physicians are venturing into the digital world. Many of them are apprehensive of tools like Facebook and the issues they create. But that Via Philippe Marchal, Giuseppe Fattori
Scoop.it!
This is an anonymous interview with a doctor specialising in geriatric medicine about her views on the pharmaceutical industry from a doctor’s perspective.
Scoop.it!
L'industrie pharmaceutique fait sa révolution... numérique
Scoop.it!
This is the presentation I delivered at the Fitness Writers' Association in London, UK. Via Philippe Marchal
Scoop.it!
Lauri Eloranta's curator insight,
January 24, 2013 6:04 PM
Over-simplistic and unrealistically positive picture of big data in healthcare. I wish it would be this easy.
Scoop.it!
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 24, 2013 9:16 AM
|
Scoop.it!
le magazine de référence e-learning. Actualités & Stratégies e-learning. Actualité et stratégies, marché, dispositifs, contenus, technologies, pratiques et tendances...
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 24, 2013 8:49 AM
|
Scoop.it!
"EMA publishes marketing application guidance for pharma" reports @pmlivecom http://t.co/ITuPxqd6 #pharma
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Veille Pharma
January 24, 2013 8:21 AM
|
Scoop.it!
As the first Big Pharma company to deliver its fourth-quarter results on Tuesday, it was perhaps fitting that Johnson & Johnson delivered a message that will be repeated on numerous occasions over the next few weeks; exposure to generic competition is diminishing – growth from new products continues to accelerate. Prescription pharmaceutical revenues for the full year stood at $25.4 billion – versus $24.4 billion in 2011.
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Digitized Health
January 24, 2013 5:29 AM
|
Scoop.it!
Exo Labs has created a camera that turns your iPad, iPhone or iPod Touch into the eye piece of your microscope.
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 24, 2013 5:22 AM
|
Scoop.it!
Alain Labrique, Ph.D., the founding director of the Johns Hopkins University Global mHealth Initiative, and his team recently conducted a survey of the mHealth studies that were registered in the government’s clinicaltrials.gov database as of November 2012. Labrique writes: ”We identified 215 unique mHealth studies that were registered in the clinicaltrials.gov database, of which 8.4 percent (n=18) were observational in nature while the remaining 91.6 percent (n=197) were interventional. Of the 215 studies, 81.8% (n=176) studies used a classical randomized trial design and 40 new studies were added to the database between May and November 2012 alone. Based on these results, we posit that the field is entering a new ‘era’ where a body of rigorous evaluation of mHealth strategies is rapidly accumulating.”
Labrique concludes: “The transition into an era of evidence-based mHealth supports our position that innovation in this domain can be evaluated with the same rigor as other public health strategies, attenuating some of the hype previously associated with mHealth.”
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Digitized Health
January 25, 2013 9:58 AM
|
Scoop.it!
This interactive textbook uses phenomenal 3D graphics to teach introductory cardiac anatomy.
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Pharmaceutical News
January 25, 2013 5:17 AM
|
Scoop.it!
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 25, 2013 1:24 AM
|
Scoop.it!
Dr Jacques Lucas - Nous sommes tous des acteurs de santé ! | http://t.co/Hl4xFe8a #health20fr #hcsmeufr #esanté
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 25, 2013 1:18 AM
|
Scoop.it!
Author of 'The Creative Destruction Of Medicine' Dr.
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Veille Pharma
January 25, 2013 1:13 AM
|
Scoop.it!
Report says mobile apps only scratch the surface of possibilities offered by mHealth. Improvement opportunities exist along the value chain, from engaging
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 25, 2013 1:08 AM
|
Scoop.it!
DHC's start of a landscape of social media in Pharma. As usual, don't be surprised if 99% are US or English language. The rest of the world doesn't do anything anyway! (there, my bugbear is over). Good start though, and should raise the bar for future initiatives.
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 24, 2013 10:39 AM
|
Scoop.it!
Le leader du diagnostic in vitro a misé sur la double expertise – technologique et métier – de SQLI dans le domaine de la Mobilité, pour la réalisation d’une gamme d’applications iPad...
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Digitized Health
January 24, 2013 9:28 AM
|
Scoop.it!
The number of Americans with diabetes is set to skyrocket in the next 40 years. Social media has given patients an online support network and information repository for dealing with their disease.
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 24, 2013 8:51 AM
|
Scoop.it!
Hotel in 92060 Paris La Défense, 92060 Paris La Défense (Reunion du Cedhys (@ Sofitel Paris La Défense) [pic]: http://t.co/szFf2KKf)
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 24, 2013 8:32 AM
|
Scoop.it!
Le Centre de recherche Pew Internet vient de publier un nouveau rapport Health Online 2013 qui souligne que 59 % des adultes américains avaient recherché de l’information en ligne sur la santé au cours de la dernière année.
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Pharma & Medical Devices
January 24, 2013 8:17 AM
|
Scoop.it!
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Veille Pharma
January 24, 2013 5:25 AM
|
Scoop.it!
Le 11ème Baromètre de l’automédication réalisé par Celtipharm pour l’Afipa propose un classement des laboratoires et des marques d'automédication en 2012. La composition du TOP 10 des laboratoires est identique à celle de l'an dernier.
